Drug Pipeline

Rintatolimod Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and… Ovarian Cancer Not Yet Recruiting
NCT03899987 Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With… Prostate Adenocarcinoma Active, Not Recruiting
Phase 1/2
NCT03734692 Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent… Ovarian Cancer Recurrent Active, Not Recruiting
Sponsors Running Rintatolimod Trials
Robert Edwards (1) Roswell Park Cancer Institute (1) Kalinski, Pawel, MD, PhD (1)
Disease Areas
Ovarian Cancer (2) Prostate Cancer (1)
Get alerts when Rintatolimod trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free